NASDAQ · HSCSW

HeartSciences Inc.

$0.07 +$0.02 (+45.44%) 1D Market open
Session Pulse Overnight session 2 mentions today 2 SEC filings since Mon close 8-K 8-K its sector ranked 6/11 this week Full pulse →
Charting by TradingView

Key Metrics

$92.08K
Market cap
—
P/E · TTM
−$13.13K
Revenue · TTM
−$9.50M
Net income
EPS · TTM $-7.57
Dividend yield —
Free cash flow −$7.34M
Beta · 1Y —
EBITDA · TTM −$8.93M
Gross margin 66.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    A material event was filed (Form 8-K).

    8-K/A - HeartSciences Inc. (0001468492) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 27
    A material event was filed (Form 8-K).

    8-K - HeartSciences Inc. (0001468492) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 23
    A material event was filed (Form 8-K).

    8-K - HeartSciences Inc. (0001468492) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap—
Enterprise value—
Shares outstanding—
52-wk range$0.03 – $0.18
Avg volume · 20D2.2K
Net cash —
Book value / share$2.11
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
ExchangeNASDAQ
About HeartSciences Inc.
IPO dateJun 15, 2022
Employees12

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S—
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—

Profitability

Gross 66.0%
Operating 68,212.3%
Net 72,383.5%
FCF 55,931.4%
ROE / ROIC -190.7% · —

Financial Health

Current ratio1.19
Quick ratio1.04
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$829.93K

Cash Flow · TTM

Operating CF −$7.34M
Capex −$3.55K
Free cash flow −$7.34M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

-19.1
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-01-31 · computed by TickerWolf from SEC filings